205 related articles for article (PubMed ID: 803748)
1. Dynamic evaluation of growth hormone (GH) and prolactin (hPRL) secretion in active acromegaly with high and low GH output.
Tolis G; Kovacs L; Friesen H; Martin JB
Acta Endocrinol (Copenh); 1975 Feb; 78(2):251-7. PubMed ID: 803748
[TBL] [Abstract][Full Text] [Related]
2. [Stimulation of growth hormone and prolactin secretion with TRH in acromegaly (author's transl)].
von Werder K; Fahlbusch R; Gay R; Pickhardt CR; Schultz B
Klin Wochenschr; 1976 Apr; 54(7):335-8. PubMed ID: 177804
[TBL] [Abstract][Full Text] [Related]
3. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
[TBL] [Abstract][Full Text] [Related]
4. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
Cantalamessa L; Reschini E; Catania A; Giustina G
Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
[TBL] [Abstract][Full Text] [Related]
5. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
Hanew K; Aida M; Tano T; Yoshinaga K
Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
[TBL] [Abstract][Full Text] [Related]
6. Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly.
Merola B; Colao A; Cataldi M; Rossi E; Longobardi S; Caruso E; Lombardi G
Horm Res; 1992; 37(1-2):7-13. PubMed ID: 1356902
[TBL] [Abstract][Full Text] [Related]
7. Disorders of prolactin and growth hormone secretion.
Ho KY; Evans WS; Thorner MO
Clin Endocrinol Metab; 1985 Feb; 14(1):1-32. PubMed ID: 3926353
[TBL] [Abstract][Full Text] [Related]
8. Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.
Müller EE; Salerno F; Cocchi D; Locatelli V; Panerai AE
Clin Endocrinol (Oxf); 1979 Dec; 11(6):645-56. PubMed ID: 119594
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
Dunn PJ; Donald RA; Espiner EA
Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
[TBL] [Abstract][Full Text] [Related]
10. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
Hara I; Kataoka K; Tomita A; Takanohashi M; Nakane T; Kuwayama A; Kageyama N
Nihon Naibunpi Gakkai Zasshi; 1979 Jan; 55(1):16-24. PubMed ID: 581754
[TBL] [Abstract][Full Text] [Related]
11. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.
Maeda K; Kato Y; Chihara K; Ogo S; Iwasaki Y
J Clin Endocrinol Metab; 1975 Aug; 41(2):408-11. PubMed ID: 239963
[TBL] [Abstract][Full Text] [Related]
12. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
Losa M; Alba-Roth J; Sobieszczyk S; Schopohl J; Müller OA; von Werder K
Acta Endocrinol (Copenh); 1989 Mar; 120(3):383-9. PubMed ID: 2494827
[TBL] [Abstract][Full Text] [Related]
13. [Comparison with growth hormone responses to various drugs or substances in patients with active acromegaly (author's transl)].
Takahara J; Ogawa N; Hosogi H; Aoki Y; Yamauchi J
Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):803-12. PubMed ID: 821792
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone responses to the releasing hormones GHRH and GnRH and the inhibitors somatostatin and bromocriptine in TRH-responsive and non-responsive acromegalics.
Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
Acta Endocrinol (Copenh); 1987 Sep; 116(1):53-8. PubMed ID: 2889308
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone releasing factor-test in acromegaly: comparison with other dynamic tests.
Losa M; Schopohl J; Stalla GK; Müller OA; von Werder K
Clin Endocrinol (Oxf); 1985 Aug; 23(2):99-109. PubMed ID: 3931944
[TBL] [Abstract][Full Text] [Related]
16. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
Marek J; Límanová Z; Srámková J
Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin-28 and somatostatin-14 suppression of arginine-, insulin-, and TRH-stimulated GH and PRL secretion in man.
Millar RP; Klaff LJ; Barron JL; Levitt NS; Ling N
Clin Endocrinol (Oxf); 1983 Mar; 18(3):277-85. PubMed ID: 6134596
[TBL] [Abstract][Full Text] [Related]
18. [Comparative studies of growth hormone secretion in acromegaly after isolated and combined application of insulin hypoglycemia, LH-RH- and TRH tests (author's transl)].
Schneider KR; Müller G; Wiegelmann W; Solbach HG; Krüskemper HL
Klin Wochenschr; 1978 May; 56(9):461-7. PubMed ID: 349258
[TBL] [Abstract][Full Text] [Related]
19. Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.
Faure N; Dussault JH; Nadeau A; Szots F; Guyda H; Labrie F
Can Med Assoc J; 1977 Sep; 117(5):478-81. PubMed ID: 409475
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone releasing factor induces prolactin secretion in acromegalic patients but not in normal subjects.
Losa M; Schopohl J; Müller OA; von Werder K
Acta Endocrinol (Copenh); 1985 Aug; 109(4):467-73. PubMed ID: 3929513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
